An update on childhood and adolescent vaccines
- PMID: 19411442
- PMCID: PMC2676128
- DOI: 10.1016/S0025-6196(11)60564-8
An update on childhood and adolescent vaccines
Abstract
In 2008, the recommendations for vaccines in children and adolescents changed substantially. The Advisory Committee on Immunization Practices expanded the routine use of influenza vaccines. New recommendations also addressed the newly licensed rotavirus vaccine. Furthermore, the Advisory Committee on Immunization Practices addressed the use of the meningococcal conjugate vaccine in children aged 2 to 10 years who are at high risk of that disease. Finally, the Food and Drug Administration and the Centers for Disease Control and Prevention reviewed the safety data collected about the human papillomavirus vaccine since its licensure and reaffirmed their recommendations for its use. This article discusses some of the important changes that should be of concern to the practitioner.
References
-
- Fiore AE, Shay DK, Broder K, et al. Advisory Committee on Immunization Practices (ACIP) Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2008. MMWR Recomm Rep. 2008;57(RR-7):1-60 - PubMed
-
- US Department of Health and Human Services, Centers for Disease Control and Prevention Interim within-season estimate of the effectiveness of trivalent inactivated influenza vaccine—Marshfield, Wisconsin, 2007-08 influenza season. MMWR Morb Mortal Wkly Rep. 2008;57:393-398 - PubMed
-
- Cortese MM, Parashar UD, US Department of Health and Human Services, Centers for Disease Control and Prevention Prevention of rotavirus gastroenteritis among infants and children: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2009;58(RR-2):1-25 - PubMed
-
- Advisory Committee on Immunization Practices Centers for Disease Control and Prevention Report from the Advisory Committee on Immunization Practices (ACIP): decision not to recommend routine vaccination of all children aged 2-10 years with quadrivalent meningococcal conjugate vaccine (MCV4). MMWR Morb Mortal Wkly Rep. 2008;57(17):462-465 - PubMed
-
- Markowitz LE, Dunne EF, Saraiya M, et al. Advisory Committee on Immunization Practices (ACIP) Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep. 2007;56(RR-2):1-24 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
